Historical Valuation
US Physical Therapy Inc (USPH) is now in the Fair zone, suggesting that its current forward PE ratio of 27.95 is considered Fairly compared with the five-year average of 34.71. The fair price of US Physical Therapy Inc (USPH) is between 80.02 to 102.82 according to relative valuation methord.
Relative Value
Fair Zone
80.02-102.82
Current Price：81.91
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
US Physical Therapy Inc (USPH) has a current Price-to-Book (P/B) ratio of 2.38. Compared to its 3-year average P/B ratio of 3.00 , the current P/B ratio is approximately -20.48% higher. Relative to its 5-year average P/B ratio of 3.65, the current P/B ratio is about -34.70% higher. US Physical Therapy Inc (USPH) has a Forward Free Cash Flow (FCF) yield of approximately 4.74%. Compared to its 3-year average FCF yield of 4.69%, the current FCF yield is approximately 1.25% lower. Relative to its 5-year average FCF yield of 4.96% , the current FCF yield is about -4.34% lower.
P/B
Median3y
3.00
Median5y
3.65
FCF Yield
Median3y
4.69
Median5y
4.96
Competitors Valuation Multiple
AI Analysis for USPH
The average P/S ratio for USPH competitors is 442.11, providing a benchmark for relative valuation. US Physical Therapy Inc Corp (USPH.N) exhibits a P/S ratio of 1.47, which is -99.67% above the industry average. Given its robust revenue growth of 17.32%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for USPH
1Y
3Y
5Y
Market capitalization of USPH increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of USPH in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is USPH currently overvalued or undervalued?
US Physical Therapy Inc (USPH) is now in the Fair zone, suggesting that its current forward PE ratio of 27.95 is considered Fairly compared with the five-year average of 34.71. The fair price of US Physical Therapy Inc (USPH) is between 80.02 to 102.82 according to relative valuation methord.
What is US Physical Therapy Inc (USPH) fair value?
USPH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of US Physical Therapy Inc (USPH) is between 80.02 to 102.82 according to relative valuation methord.
How does USPH's valuation metrics compare to the industry average?
The average P/S ratio for USPH's competitors is 442.11, providing a benchmark for relative valuation. US Physical Therapy Inc Corp (USPH) exhibits a P/S ratio of 1.47, which is -99.67% above the industry average. Given its robust revenue growth of 17.32%, this premium appears unsustainable.
What is the current P/B ratio for US Physical Therapy Inc (USPH) as of Jan 09 2026?
As of Jan 09 2026, US Physical Therapy Inc (USPH) has a P/B ratio of 2.38. This indicates that the market values USPH at 2.38 times its book value.
What is the current FCF Yield for US Physical Therapy Inc (USPH) as of Jan 09 2026?
As of Jan 09 2026, US Physical Therapy Inc (USPH) has a FCF Yield of 4.74%. This means that for every dollar of US Physical Therapy Inc’s market capitalization, the company generates 4.74 cents in free cash flow.
What is the current Forward P/E ratio for US Physical Therapy Inc (USPH) as of Jan 09 2026?
As of Jan 09 2026, US Physical Therapy Inc (USPH) has a Forward P/E ratio of 27.95. This means the market is willing to pay $27.95 for every dollar of US Physical Therapy Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for US Physical Therapy Inc (USPH) as of Jan 09 2026?
As of Jan 09 2026, US Physical Therapy Inc (USPH) has a Forward P/S ratio of 1.47. This means the market is valuing USPH at $1.47 for every dollar of expected revenue over the next 12 months.